Tress

Tress is a biotechnology company focused on developing novel therapeutic solutions for hair loss, specifically targeting androgenetic alopecia. The company leverages a deep understanding of the molecular mechanisms underlying hair follicle biology to design small molecule treatments that address the root causes of thinning and balding. By focusing on the androgen receptor pathway and other key regulators of the hair growth cycle, Tress aims to provide more effective and safer alternatives to current standard-of-care treatments. The company's approach combines advanced drug discovery techniques with a specialized focus on dermatology and regenerative medicine.